Current Neurology and Neuroscience Reports

, Volume 9, Issue 6, pp 469–476 | Cite as

Status epilepticus

Article

Abstract

Status epilepticus (SE) still results in significant mortality and morbidity. Whereas mortality depends mainly on the age of the patient as well as etiology, morbidity often results from a myriad of complications that occur during prolonged admission to an intensive care environment. Although SE is a clinical diagnosis in most cases (convulsant), its treatment requires support by continuous electroencephalographic recording to ensure cessation of potential nonconvulsive elements of SE. Treatment must be initiated as early as possible and consists of benzodiazepine administration and supportive measures for the airway and circulation. These initial interventions are followed by effective intravenous antiepileptic drugs. If the SE becomes refractory, more complex intensive care interventions, such as induction of barbiturate coma, need to be pursued. Data regarding the role of more recently available antiepileptic drugs in treating SE also are discussed in this review.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Kaplan PW: Assessing the outcomes in patients with nonconvulsive status epilepticus: nonconvulsive status epilepticus is underdiagnosed, potentially overtreated, and confounded by comorbidity. J Clin Neurophysiol 1999, 16:341–352.CrossRefPubMedGoogle Scholar
  2. 2.
    Towne AR, Pellock JM, Ko D, DeLorenzo RJ: Determinants of mortality in status epilepticus. Epilepsia 1994, 35:27–34.CrossRefPubMedGoogle Scholar
  3. 3.
    Treiman DM, Meyers PD, Walton NY, et al.: A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med 1998, 339:792–798.CrossRefPubMedGoogle Scholar
  4. 4.
    DeLorenzo RJ, Towne AR, Pellock JM, Ko D: Status epilepticus in children, adults, and the elderly. Epilepsia 1992, 33(Suppl 4):S15–S25.CrossRefPubMedGoogle Scholar
  5. 5.
    Legriel S, Mourvillier B, Bele N, et al.: Outcomes in 140 critically ill patients with status epilepticus. Intensive Care Med 2008, 34:476–480.CrossRefPubMedGoogle Scholar
  6. 6.
    Gastaut H: Classification of status epilepticus. Adv Neurol 1983, 34:15–35.PubMedGoogle Scholar
  7. 7.
    Treatment of convulsive status epilepticus. Recommendations of the Epilepsy Foundation of America’s Working Group on Status Epilepticus. JAMA 1993, 270:854–859.Google Scholar
  8. 8.
    Millikan D, Rice B, Silbergleit R: Emergency treatment of status epilepticus: current thinking. Emerg Med Clin North Am 2009, 27:101–113, ix.CrossRefPubMedGoogle Scholar
  9. 9.
    Bleck TP: Convulsive disorders: status epilepticus. Clin Neuropharmacol 1991, 14:191–198.PubMedGoogle Scholar
  10. 10.
    Lowenstein DH, Bleck T, Macdonald RL: It’s time to revise the definition of status epilepticus. Epilepsia 1999, 40:120–122.CrossRefPubMedGoogle Scholar
  11. 11.
    Lowenstein DH: The management of refractory status epilepticus: an update. Epilepsia 2006, 47(Suppl 1):35–40.CrossRefPubMedGoogle Scholar
  12. 12.
    Walker MC: Diagnosis and treatment of nonconvulsive status epilepticus. CNS Drugs 2001, 15:931–939.CrossRefPubMedGoogle Scholar
  13. 13.
    Hauser WA: Status epilepticus: epidemiologic considerations. Neurology 1990, 40:9–13.PubMedGoogle Scholar
  14. 14.
    DeLorenzo RJ, Hauser WA, Towne AR, et al.: A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology 1996, 46:1029–1035.PubMedGoogle Scholar
  15. 15.
    Jordan KG: Nonconvulsive status epilepticus in acute brain injury. J Clin Neurophysiol 1999, 16:332–340; discussion 53.CrossRefPubMedGoogle Scholar
  16. 16.
    Towne AR, Waterhouse EJ, Boggs JG, et al.: Prevalence of nonconvulsive status epilepticus in comatose patients. Neurology 2000, 54:340–345.PubMedGoogle Scholar
  17. 17.
    Claassen J, Jette N, Chum F, et al.: Electrographic seizures and periodic discharges after intracerebral hemorrhage. Neurology 2007, 69:1356–1365.CrossRefPubMedGoogle Scholar
  18. 18.
    Claassen J, Peery S, Kreiter KT, et al.: Predictors and clinical impact of epilepsy after subarachnoid hemorrhage. Neurology 2003, 60:208–214.PubMedGoogle Scholar
  19. 19.
    Cocito L, Audenino D, Primavera A: Altered mental state and nonconvulsive status epilepticus in patients with cancer. Arch Neurol 2001, 58:1310.CrossRefPubMedGoogle Scholar
  20. 20.
    Vespa PM, Nuwer MR, Nenov V, et al.: Increased incidence and impact of nonconvulsive and convulsive seizures after traumatic brain injury as detected by continuous electroencephalographic monitoring. J Neurosurg 1999, 91:750–760.CrossRefPubMedGoogle Scholar
  21. 21.
    Carrera E, Michel P, Despland PA, et al.: Continuous assessment of electrical epileptic activity in acute stroke. Neurology 2006, 67:99–104.CrossRefPubMedGoogle Scholar
  22. 22.
    Mayer SA, Claassen J, Lokin J, et al.: Refractory status epilepticus: frequency, risk factors, and impact on outcome. Arch Neurol 2002, 59:205–210.CrossRefPubMedGoogle Scholar
  23. 23.
    Wijdicks EF, Sharbrough FW: New-onset seizures in critically ill patients. Neurology 1993, 43:1042–1044.PubMedGoogle Scholar
  24. 24.
    Bleck TP, Smith MC, Pierre-Louis SJ, et al.: Neurologic complications of critical medical illnesses. Crit Care Med 1993, 21:98–103.PubMedCrossRefGoogle Scholar
  25. 25.
    Drislane FW, Lopez MR, Blum AS, Schomer DL: Detection and treatment of refractory status epilepticus in the intensive care unit. J Clin Neurophysiol 2008, 25:181–186.CrossRefPubMedGoogle Scholar
  26. 26.
    Lowenstein DH, Alldredge BK: Status epilepticus. N Engl J Med 1998, 338:970–976.CrossRefPubMedGoogle Scholar
  27. 27.
    Fountain NB: Status epilepticus: risk factors and complications. Epilepsia 2000, 41(Suppl 2):S23–S30.CrossRefPubMedGoogle Scholar
  28. 28.
    Loscher W: Mechanisms of drug resistance in status epilepticus. Epilepsia 2007, 48(Suppl 8):74–77.CrossRefPubMedGoogle Scholar
  29. 29.
    Bankstahl JP, Loscher W: Resistance to antiepileptic drugs and expression of P-glycoprotein in two rat models of status epilepticus. Epilepsy Res 2008, 82:70–85.CrossRefPubMedGoogle Scholar
  30. 30.
    Meldrum BS, Vigouroux RA, Brierley JB: Systemic factors and epileptic brain damage. Prolonged seizures in paralyzed, artificially ventilated baboons. Arch Neurol 1973, 29:82–87.PubMedGoogle Scholar
  31. 31.
    Aminoff MJ, Simon RP: Status epilepticus. Causes, clinical features and consequences in 98 patients. Am J Med 1980, 69:657–666.CrossRefPubMedGoogle Scholar
  32. 32.
    DeLorenzo RJ, Waterhouse EJ, Towne AR, et al.: Persistent nonconvulsive status epilepticus after the control of convulsive status epilepticus. Epilepsia 1998, 39:833–840.CrossRefPubMedGoogle Scholar
  33. 33.
    Brenner RP: Is it status? Epilepsia 2002, 43(Suppl 3):103–113.CrossRefPubMedGoogle Scholar
  34. 34.
    Kaplan PW: The EEG of status epilepticus. J Clin Neurophysiol 2006, 23:221–229.CrossRefPubMedGoogle Scholar
  35. 35.
    Hirsch LJ, Claassen J, Mayer SA, Emerson RG: Stimulusinduced rhythmic, periodic, or ictal discharges (SIRPIDs): a common EEG phenomenon in the critically ill. Epilepsia 2004, 45:109–123.CrossRefPubMedGoogle Scholar
  36. 36.
    Alldredge BK, Gelb AM, Isaacs SM, et al.: A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Engl J Med 2001, 345:631–637.CrossRefPubMedGoogle Scholar
  37. 37.
    Agarwal P, Kumar N, Chandra R, et al.: Randomized study of intravenous valproate and phenytoin in status epilepticus. Seizure 2007, 16:527–532.CrossRefPubMedGoogle Scholar
  38. 38.
    Schulze-Bonhage A, Kurthen M, Walger P, Elger CE: Pharmacorefractory status epilepticus due to low vitamin B6 levels during pregnancy. Epilepsia 2004, 45:81–84.CrossRefPubMedGoogle Scholar
  39. 39.
    Iannetti P, Spalice A, Parisi P: Calcium-channel blocker verapamil administration in prolonged and refractory status epilepticus. Epilepsia 2005, 46:967–969.CrossRefPubMedGoogle Scholar
  40. 40.
    Claassen J, Hirsch LJ, Emerson RG, Mayer SA: Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review. Epilepsia 2002, 43:146–153.CrossRefPubMedGoogle Scholar
  41. 41.
    Krishnamurthy KB, Drislane FW: Depth of EEG suppression and outcome in barbiturate anesthetic treatment for refractory status epilepticus. Epilepsia 1999, 40:759–762.CrossRefPubMedGoogle Scholar
  42. 42.
    Treiman DM: Convulsive status epilepticus. Curr Treat Options Neurol 1999, 1:359–369.CrossRefPubMedGoogle Scholar
  43. 43.
    Krishnamurthy KB, Drislane FW: Relapse and survival after barbiturate anesthetic treatment of refractory status epilepticus. Epilepsia 1996, 37:863–867.CrossRefPubMedGoogle Scholar
  44. 44.
    Rossetti AO, Logroscino G, Bromfield EB: Refractory status epilepticus: effect of treatment aggressiveness on prognosis. Arch Neurol 2005, 62:1698–1702.CrossRefPubMedGoogle Scholar
  45. 45.
    Rossetti AO, Bromfield EB: Determinants of success in the use of oral levetiracetam in status epilepticus. Epilepsy Behav 2006, 8:651–654.CrossRefPubMedGoogle Scholar
  46. 46.
    Ruegg S, Naegelin Y, Hardmeier M, et al.: Intravenous levetiracetam: treatment experience with the first 50 critically ill patients. Epilepsy Behav 2008, 12:477–480.CrossRefPubMedGoogle Scholar
  47. 47.
    Knake S, Gruener J, Hattemer K, et al.: Intravenous levetiracetam in the treatment of benzodiazepine refractory status epilepticus. J Neurol Neurosurg Psychiatry 2008, 79:588–589.CrossRefPubMedGoogle Scholar
  48. 48.
    Kellinghaus C, Berning S, Besselmann M: Intravenous lacosamide as successful treatment for nonconvulsive status epilepticus after failure of first-line therapy. Epilepsy Behav 2009, 14:429–431.CrossRefPubMedGoogle Scholar
  49. 49.
    Towne AR, Garnett LK, Waterhouse EJ, et al.: The use of topiramate in refractory status epilepticus. Neurology 2003, 60:332–334.PubMedGoogle Scholar
  50. 50.
    Corry JJ, Dhar R, Murphy T, Diringer MN: Hypothermia for refractory status epilepticus. Neurocrit Care 2008, 9:189–197.CrossRefPubMedGoogle Scholar
  51. 51.
    Varelas PN: How I treat status epilepticus in the Neuro-ICU. Neurocrit Care 2008, 9:153–157.CrossRefPubMedGoogle Scholar
  52. 52.
    Ziai WC, Kaplan PW: Seizures and status epilepticus in the intensive care unit. Semin Neurol 2008, 28:668–681.CrossRefPubMedGoogle Scholar
  53. 53.
    Robakis TK, Hirsch LJ: Literature review, case report, and expert discussion of prolonged refractory status epilepticus. Neurocrit Care 2006, 4:35–46.CrossRefPubMedGoogle Scholar
  54. 54.
    Rossetti AO, Oddo M, Liaudet L, Kaplan PW: Predictors of awakening from postanoxic status epilepticus after therapeutic hypothermia. Neurology 2009, 72:744–749.CrossRefPubMedGoogle Scholar
  55. 55.
    Hesdorffer DC, Logroscino G, Cascino GD, Hauser WA: Recurrence of afebrile status epilepticus in a population-based study in Rochester, Minnesota. Neurology 2007, 69:73–78.CrossRefPubMedGoogle Scholar
  56. 56.
    Varelas PN, Mirski MA: Seizures in the adult intensive care unit. J Neurosurg Anesthesiol 2001, 13:163–175.CrossRefPubMedGoogle Scholar

Copyright information

© Current Medicine Group, LLC 2009

Authors and Affiliations

  1. 1.Department of Neurology and NeurosurgeryHenry Ford HospitalDetroitUSA

Personalised recommendations